Exploring social dysfunction in schizophrenia through brain activity
Official title: HYEEG Discourse in Psychosis: A Neurobehavioural Study
Run by Douglas Mental Health University Institute · NCT06978803 · Data updated 2026-11-12
This study is trying to see how brain activity during social interactions affects communication and social skills in people with schizophrenia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Douglas Mental Health University Institute Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | January 16, 2024 |
| Main results expected | October 22, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT06978803 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English or French-speaking individuals aged 18-60 with a diagnosis of schizophrenia or schizoaffective disorder and less than 5 years since illness onset.
✕Probably not a fit
Patients with primary diagnoses of substance abuse, severe medical disorders, or neurological conditions affecting speech may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the mechanisms of social dysfunction in individuals with schizophrenia by examining the relationship between disorganized communication and social interaction. Participants will engage in structured social interactions while undergoing dual-brain EEG hyperscanning to measure neural and behavioral synchrony. The study aims to identify measurable markers of disorganized communication and link them to clinical symptoms and social functioning, focusing on aspects such as motor imitation and verbal coherence.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and interventions for social dysfunction in patients with schizophrenia.
How similar studies have gone: While the specific approach of dual-brain EEG hyperscanning is relatively novel, similar studies have shown promise in understanding social cognition in psychiatric disorders.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. English or French-speaking participants (as dyads matched for language preference). 2. Ages 18-60 years. 3. Patients meeting the operational criteria for schizophrenia or schizoaffective illness as previously diagnosed by their treating psychiatrist, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 criteria (Zipursky et al., 2020). 4. Patients with less than 5 years of illness onset, based on the time of starting treatment with antipsychotic medication. Exclusion Criteria: 1. Participants should not have a primary diagnosis of Alcohol or Drug abuse or addiction (however, co-morbid substance abuse with a primary diagnosis of psychotic disorder is not an exclusion criterion). 2. Participants should not have a severe medical disorder that would explain psychotic symptoms. 3. Participants should not have a past or current history of a primary neurological disorder that can affect speech output 4. Participants with IQ below 70 or a concurrent pervasive developmental disorder (e.g., autism) will also be excluded.
Where it's running
-
Douglas Mental Health University Institute
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Lena Palaniyappan, MD, PhD — Douglas Mental Health University Institute
- Study coordinator: Emmanuel Olarewaju, PhD Candidate
- Email: emmanuel.olarewaju@mail.mcgill.ca
- Phone: 5147616131
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Combined brain stimulation and yoga for improving cognition in psychosis
This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.
-
See if an early-detection program reduces time to treatment for first-episode psychosis
We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.
-
Transition Support for First-Episode Psychosis
A team-based program helps people experiencing their first psychotic episode move from hospital to outpatient care to see if they stay engaged and feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.